SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filings

Filing date Form Description Filing Group View
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
5

Annual filing director officer or owner of more than ten percent.

3,4,5
View HTML
5

Annual filing director officer or owner of more than ten percent.

3,4,5
View HTML
5

Annual filing director officer or owner of more than ten percent.

3,4,5
View HTML
5

Annual filing director officer or owner of more than ten percent.

3,4,5
View HTML
5

Annual filing director officer or owner of more than ten percent

3,4,5
View HTML
ARS

An annual report to security holders

Annual Filings
View HTML

Data provided by Kaleidoscope.